Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brent Boyse

Dentist, Oral and Maxillofacial Surgery Mesa, AZ Doctor of Dentistry

NPI 1609853365 CMS profile 921421

6755 E Superstition Springs Blvd, Suite 103, Mesa, AZ 85206

Open in the dashboard

General payments

$201,162

409 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brent Boyse of Mesa, AZ is reported in the CMS Open Payments database as having received $201,162 across 409 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,269 53
2024 General $63,660 131
2023 General $39,487 89
2022 General $27,624 45
2021 General $10,070 22
2020 General $8,435 20
2019 General $24,617 49

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brent Boyse
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Brent Boyse were reported at $27,269. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Brent Boyse Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $24,617 $142 $50–$420 $163
2020 $8,435 $96 $36–$277 $114
2021 $10,070 $138 $45–$419 $132
2022 $27,624 $144 $48–$367 $149
2023 $39,487 $153 $55–$399 $160
2024 $63,660 $152 $50–$400 $164
2025 $27,269 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimvie Inc. $157,113 304 payments
  2. Zimmer Biomet Holdings, Inc. $43,064 87 payments
  3. BioHorizons Implant Systems Inc. $611 9 payments
  4. Geistlich Pharma, North America, Inc. $187 2 payments
  5. Nobel Biocare USA $103 2 payments
  6. KLS-Martin L.P. $35 3 payments
  7. Henry Schein, Inc. $28 1 payment
  8. Keystone Dental Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $170,245 88 payments
  2. Travel and Lodging $20,680 108 payments
  3. Food and Beverage $10,236 213 payments
Products named General payments · program years 2019–2025
  1. Zimmer Biomet Instruments and Implants $30,108 18 payments
  2. T3 $27,577 28 payments
  3. TSX Implants $24,991 23 payments
  4. Diem2-RevitaliZe $21,459 21 payments
  5. OSSEOTITE NT $17,608 9 payments
  6. 3i T3 $17,231 45 payments
  7. Tapered Screw-Vent $13,587 121 payments
  8. 3DIEMME RealGUIDE $8,493 6 payments
  9. Dental-None $7,101 5 payments
  10. Diem2 $3,585 34 payments
  11. Other $9,556 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

812

Median for Oral Surgery (Dentist only): 288

Drug cost

$5,250

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

28.4%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 87 $974
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 107 $871
Chlorhexidine Gluconate Generic 173 $680
Ibuprofen Generic 119 $568
Cefdinir Generic 24 $566
Amoxicillin Generic 159 $472
Moxifloxacin Hcl Generic 12 $361
Azithromycin Generic 16 $146
Fluconazole Generic 14 $144
Clindamycin Hcl Generic 16 $142

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Records

409 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record